Ibex Medical Analytics’ $38 Million Series B Funding Round

In UK Goodwin Procter, advised on the matter.

Goodwin Procter advised 83North Ltd., Octopus Ventures Ltd with a team including Ali Ramadan (IP&IT), William Schnoor Jr. (Picture – Corporate M&A), Gretchen Scott (IP&IT).

83North and Octopus Ventures announced their lead investment into Ibex Medical Analytics, an Israeli based AI-powered cancer diagnostics company, as part of a $38 million Series B funding round. aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital (the corporate venture arm of Dell Technologies) also participated in the round. The company has now raised a total of $52 million since its launch in 2016.

83North is a global venture capital firm with over $1.8 billion under management. The fund invests across all stages in exceptional entrepreneurs whose focus is to build global category-leading companies.

Octopus Ventures is one of Europe’s largest and most active Venture Capital firms investing in startups in the areas of health, money, deep tech and consumer.

The Goodwin team was led by Bill Schnoor (Picture), Ali Ramadan, Gretchen Scott, Ella Donegan, Liz Rhodes and Anna Kaye.

 

Involved fees earner: Ella Donegan – Goodwin Procter; Ali Ramadan – Goodwin Procter; Elizabeth Rhodes – Goodwin Procter; William Schnoor Jr. – Goodwin Procter; Gretchen Scott – Goodwin Procter;

Law Firms: Goodwin Procter;

Clients: 83North Ltd.; Octopus Ventures Ltd;